Research Article

Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors

Volume: 55 Number: 2 September 23, 2025
EN

Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors

Abstract

Background and Aims: Inhibiting the α-glucosidase reduces the rate at which glucose is absorbed, helping to control blood sugar levels. This strategy presents a potential alternative for managing type 2 diabetes, offering a promising approach with fewer adverse effects compared with conventional treatments. Based on this, we synthesised novel imidazo[2,1-b]thiazole-based 4-thiazolidinone derivatives (5a-e) and eval uated them for their α-glucosidase inhibitory activities. Methods: Structural confirmation of the synthesised compounds was carried out using various spectro scopic techniques, including IR, ¹H-NMR and ¹³C-NMR spectroscopy, elemental analysis and ESI-MS. The newly synthesised compounds were subjected to in vitro evaluation to assess their inhibitory effects on α-glucosidase activity. Results: Spectroscopic analyses confirmed the successful synthesis of the target compounds. Among them, compound 5e exhibited the most potent α-glucosidase inhibitory effect, with a half-maximal inhibitory concentration (IC₅₀) value of 115.94 ± 0.58 µM, outperforming the standard drug acarbose, which showed an IC₅₀ of 179.25 ± 3.41 µM. Conclusion: In summary, a series of novel imidazo[2,1-b]thiazole-based 4-thiazolidinone derivatives (5a-e) were successfully synthesised, among which compound 5e emerged as the most potent α-glucosidase inhibitor, surpassing the activity of the reference drug acarbose. These findings position compound 5e as a promising lead candidate for developing new α-glucosidase inhibitory agents. To fully assess the therapeutic value of this scaffold, further in vitro investigations on structurally related analogs, followed by comprehensive in vivo assessments, are warranted.

Keywords

References

  1. Andreani, A., Granaiola, M., Leoni, A., Locatelli, A., Morigi, R., & Rambaldi, M. (2001). Synthesis and antitubercular activity of imidazo[2,1-b]thiazoles. European Journal of Medicinal Chemistry, 36(9), 743–746. https://doi.org/10.1016/s0223-5234(01)01266-1 google scholar
  2. Bothon, F. T., Debiton, E., Avlessi, F., Forestier, C., Teulade, J. C., & Sohounhloue, D. K. (2013). In vitro biological effects of two anti-diabetic medicinal plants used in Benin as folk medicine. BMC Alternative and Complementary Medicine, 13, 51. https://doi.org/10.1186/1472-6882-13-51 google scholar
  3. Cihan-Ustundag, G., Gursoy, E., Naesens, L., Ulusoy-Guzeldemirci, N., & Capan, G. (2016). Synthesis and antiviral properties of novel indole-based thiosemicarbazides and 4-thiazolidinones. Bioorganic & Medicinal Chemistry, 24(2), 240– 246. https://doi.org/10.1016/j.bmc.2015.12.008 google scholar
  4. Deep, A., Jain, S., Sharma, P. C., Phogat, P., & Malhotra, M. (2011). Synthesis of 2-(aryl)-5-(arylidene)-4-thiazolidinone derivatives with potential analgesic and anti-inflammatory activity. Medicinal Chemistry Research, 21(8), 1652–1659. https://doi.org/10.1007/s00044-011-9679-0 google scholar
  5. Desouza, C. V., & Shivaswamy, V. (2010). Pioglitazone in the treatment of type 2 diabetes: safety and efficacy review. Clinical Medicine Insights: Endocrinology and Diabetes, 3, 43–51. https://doi.org/10.4137/cmed.s5372 google scholar
  6. Dincel, E. D., Hasbal-Celikok, G., Yilmaz-Ozden, T., & Ulusoy-Güzeldemirci, N. (2021). Design, biological evaluation, molecular docking study and in silico ADME prediction of novel imidazo[2,1-b]thiazole derivatives as a novel class of α-glucosidase inhibitors. Journal of Molecular Structure, 1245. https://doi.org/10. 1016/j.molstruc.2021.131260 google scholar
  7. Dincel, E. D., Hasbal-Celikok, G., Yilmaz-Ozden, T., & Ulusoy-Güzeldemirci, N. (2022). Design, synthesis, biological evaluation, molecular docking, and dynamic simulation study of novel imidazo[2,1-b]thiazole derivatives as potent antioxidant agents. Journal of Molecular Structure, 1258. https://doi.org/10.1016/j.molstruc. 2022.132673 google scholar
  8. Fischer, W., Bodewei, R., & Satzinger, G. (1992). Anticonvulsant and sodium channel blocking effects of ralitoline in different screening models. Naunyn-Schmiedeberg’s Archives of Pharmacology, 346(4), 442–452. https://doi.org/10. 1007/BF00171088 google scholar

Details

Primary Language

English

Subjects

Pharmaceutical Chemistry

Journal Section

Research Article

Publication Date

September 23, 2025

Submission Date

December 12, 2024

Acceptance Date

May 21, 2025

Published in Issue

Year 2025 Volume: 55 Number: 2

APA
Dincel, E. D., Hasbal Çelikok, G., Yılmaz Özden, T., & Ulusoy Güzeldemirci, N. (2025). Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors. İstanbul Journal of Pharmacy, 55(2), 183-190. https://doi.org/10.26650/IstanbulJPharm.2025.1600357
AMA
1.Dincel ED, Hasbal Çelikok G, Yılmaz Özden T, Ulusoy Güzeldemirci N. Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors. iujp. 2025;55(2):183-190. doi:10.26650/IstanbulJPharm.2025.1600357
Chicago
Dincel, Efe Doğukan, Gözde Hasbal Çelikok, Tuğba Yılmaz Özden, and Nuray Ulusoy Güzeldemirci. 2025. “Design and Synthesis of Novel Imidazo[2,1-B]thiazole-Based 4- Thiazolidinone Derivatives As Potent α-Glucosidase Inhibitors”. İstanbul Journal of Pharmacy 55 (2): 183-90. https://doi.org/10.26650/IstanbulJPharm.2025.1600357.
EndNote
Dincel ED, Hasbal Çelikok G, Yılmaz Özden T, Ulusoy Güzeldemirci N (September 1, 2025) Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors. İstanbul Journal of Pharmacy 55 2 183–190.
IEEE
[1]E. D. Dincel, G. Hasbal Çelikok, T. Yılmaz Özden, and N. Ulusoy Güzeldemirci, “Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors”, iujp, vol. 55, no. 2, pp. 183–190, Sept. 2025, doi: 10.26650/IstanbulJPharm.2025.1600357.
ISNAD
Dincel, Efe Doğukan - Hasbal Çelikok, Gözde - Yılmaz Özden, Tuğba - Ulusoy Güzeldemirci, Nuray. “Design and Synthesis of Novel Imidazo[2,1-B]thiazole-Based 4- Thiazolidinone Derivatives As Potent α-Glucosidase Inhibitors”. İstanbul Journal of Pharmacy 55/2 (September 1, 2025): 183-190. https://doi.org/10.26650/IstanbulJPharm.2025.1600357.
JAMA
1.Dincel ED, Hasbal Çelikok G, Yılmaz Özden T, Ulusoy Güzeldemirci N. Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors. iujp. 2025;55:183–190.
MLA
Dincel, Efe Doğukan, et al. “Design and Synthesis of Novel Imidazo[2,1-B]thiazole-Based 4- Thiazolidinone Derivatives As Potent α-Glucosidase Inhibitors”. İstanbul Journal of Pharmacy, vol. 55, no. 2, Sept. 2025, pp. 183-90, doi:10.26650/IstanbulJPharm.2025.1600357.
Vancouver
1.Efe Doğukan Dincel, Gözde Hasbal Çelikok, Tuğba Yılmaz Özden, Nuray Ulusoy Güzeldemirci. Design and Synthesis of Novel Imidazo[2,1-b]thiazole-Based 4- Thiazolidinone Derivatives as Potent α-Glucosidase Inhibitors. iujp. 2025 Sep. 1;55(2):183-90. doi:10.26650/IstanbulJPharm.2025.1600357